CAS: 1312299-39-0
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Concizumab REF: TM-T77373CAS: 1312299-39-0 | SDS-PAGE:95% SEC-HPLC:95% | 270,00 €~3.048,00 € | Mar 15 Oct 24 |
 | Concizumab REF: 3D-CLA1315CAS: 1312299-39-0 | - - - | A consultar | Jue 24 Oct 24 |
Concizumab
CAS:1312299-39-0
Concizumab is an anti-TFPI monoclonal antibody (IgG4 type) that selectively binds to the Kunitz protease …
Pureza:
SDS-PAGE:95% SEC-HPLC:95%
Forma y color:
Solid
Ref: TM-T77373
| 1mg | 270,00 € | ||
| 5mg | 704,00 € | ||
| 10mg | 1.112,00 € | ||
| 25mg | 1.660,00 € | ||
| 50mg | 2.255,00 € | ||
| 100mg | 3.048,00 € |
Entrega estimada en Estados Unidos, el Martes 15 de Octubre de 2024
Concizumab
CAS:1312299-39-0
A neutralizing human monoclonal antibody that blocks Macrophage-stimulating 1-receptor (RON) binding to macrophage-stimulating protein (MSP).
Ref: 3D-CLA1315
| Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Jueves 24 de Octubre de 2024
